Growth Metrics

Biocryst Pharmaceuticals (BCRX) EPS (Basic): 2009-2014

Historic EPS (Basic) for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -$0.68.

  • Biocryst Pharmaceuticals' EPS (Basic) fell 66.67% to -$0.20 in Q3 2015 from the same period last year, while for Sep 2015 it was -$0.50, marking a year-over-year increase of 18.03%. This contributed to the annual value of -$0.68 for FY2014, which is 23.64% down from last year.
  • Biocryst Pharmaceuticals' EPS (Basic) amounted to -$0.68 in FY2014, which was down 23.64% from -$0.55 recorded in FY2013.
  • Over the past 5 years, Biocryst Pharmaceuticals' EPS (Basic) peaked at -$0.55 during FY2013, and registered a low of -$1.26 during FY2011.
  • In the last 3 years, Biocryst Pharmaceuticals' EPS (Basic) had a median value of -$0.68 in 2014 and averaged -$0.67.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' EPS (Basic) slumped by 117.14% in 2010, and later surged by 37.30% in 2012.
  • Over the past 5 years, Biocryst Pharmaceuticals' EPS (Basic) (Yearly) stood at -$0.76 in 2010, then slumped by 65.79% to -$1.26 in 2011, then surged by 37.30% to -$0.79 in 2012, then soared by 30.38% to -$0.55 in 2013, then decreased by 23.64% to -$0.68 in 2014.